Camden Biotechnology began operations in September $2024.$ The following selected transactions

relate to liabilities of the company for September $2024$ through March $2025.$ Camden's fiscal year ends

on December $31.$ Its financial statements are issued in April.

$2024$

a$.$ On September $5,$ opened checking accounts at Second Commercial Bank and negotiated a short$-$

term line of credit of up to $$15,000,000$ at the bank's prime rate $(10\mathrm{.}5\%$ at the time$).$ The company will

pay no commitment fees.

On October $1,$ borrowed $$12$ million cash from Second Commercial Bank under the line of credit

and issued a five$-$month promissory note. Interest at the prime rate of $10\%$ was payable at maturity.

Management planned to issue $10-$year bonds in February to repay the note.

$.$ Received $$2,600$ of refundable deposits in December for reusable containers used to transport and

store chemical$-$based products.

d$.$ For the September$-$December period, sales on account totaled $$4,100,000.$ The state sales tax

rate is $3\%$ and the local sales tax rate is $3\%.($This is a summary journal entry for the many individual

sales transactions for the period.$)$

Recorded the adjusting entry for accrued interest.

$2025$

In March, paid the entire amount of the note on its March $1$ due date, using proceeds from a

February issuance of $$10$ million of $10-$year bonds at face value, along with other available cash.

The storage containers covered by refundable deposits are expected to be returned during the first

nine months of the year. Half of the containers were returned in March $2025.$

Required:

Prepare the appropriate journal entries for items a$-$g$.$

Prepare the current and long$-$term liability sections of the December $31,2024,$ balance sheet. Trade

accounts payable on that date were $$252,000.$